Banner
Your banner contains a hero image with text overlay. You can also add call to action buttons.
Older age |
|
|
Family history of affective disorders |
Risk for early onset, chronicity, and non-response. Positive response to a medication by a family member may predict a response in the patient and vice versa |
|
Personality traits |
High neuroticism; other associated personality traits (low extraversion, openness, and conscientiousness) |
|
History of abuse |
History of physical, emotional, and/or sexual abuse at any stage in life |
|
Any childhood maltreatment |
Any form of childhood maltreatment |
|
Multiple childhood maltreatment |
||
Duration of illness |
A long duration of illness |
|
Early onset <18 |
||
Late onset >60 |
||
Recurrent episodes |
Risk compared with single MDE |
|
Severity |
Greater severity |
|
No. of hospitalizations |
If more than 1 psychiatric admission |
|
Suicide risk |
Current elevated suicidal risk as indicated by ideations |
|
Quality of remission |
Lack of full remission |
|
Anhedonia |
Persistent anhedonia a risk for chronicity, lack of remission and relapse |
|
Dysthymia |
Increased risk of relapse and lack of full remission |
|
Comorbid anxiety disorder |
||
Comorbid panic disorder |
||
Comorbid social phobia |
||
Comorbid personality disorder |
||
Comorbid PTSD |
||
Comorbid medical illness |
Includes endocrine disorders, diabetes (poor glycemic control), neurological disorders, pancreatic carcinoma, connective tissue disorders, vitamin deficiency, viral infections, obesity, and coronary heart disease |
|
Substance abuse |
Bidirectional effects – both exacerbate and maintain the other |
|
First antidepressant |
Non- or delayed- response to the first antidepressant |
|
Dosage |
Sub-optimal dosing |
|
Duration of treatment |
Early discontinuation |
|
Tolerance/side effects |
Through discontinuation or sub-optimal dosing |
|
Non-adherence |
||
Pharmacokinetics |
Rapid metabolism, malabsorption etc. leading to sub-therapeutic serum levels |